Tecifedra, also known as dimethyl fumerate or BG12, is the first Nrf2 activator that has been approved by FDA as a treatment for multiple sclerosis [32] and there are other molecules under development for multiple other diseases. The gene discussed is NFE2L2; the disease is multiple sclerosis.